drugset / Trial / NCT00005614
Management of Metastatic Breast Cancer in Frail Patients
Phase 2
Withdrawn
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of gemcitabine in treating elderly women who have metastatic breast cancer.
Timeline
- Start
- 1999-08
- Primary completion
- 2000-06
- Completion
- 2000-06
Outcome
Outcome not reported
Stopped (Enrollment): “no accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | — | Intravenous |